Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07427 | 32504663 | J Hepatol | Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. | 2020 | Details |
| A07428 | 32503411 | Mol Med | The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A07429 | 32502647 | Biochim Biophys Acta Mol Basis Dis | The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis. | 2020 | Details |
| A07430 | 32502637 | Pharmacol Res | Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. | 2020 | Details |
| A07431 | 32502037 | Medicine (Baltimore) | Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease. | 2020 | Details |
| A07432 | 32499918 | Gastroenterol Rep (Oxf) | Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study. | 2019 | Details |
| A07433 | 32499209 | J Formos Med Assoc | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. | 2020 | Details |
| A07434 | 32498337 | Nutrients | Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study. | 2020 | Details |
| A07435 | 32498134 | Hepatology | Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver. | 2020 | Details |
| A07436 | 32497536 | Metabolism | Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance. | 2020 | Details |
| A07438 | 32496563 | Endocrinology | LXRα Phosphorylation in Cardiometabolic Disease: Insight From Mouse Models. | 2020 | Details |
| A07439 | 32496342 | Am J Gastroenterol | Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. | 2020 | Details |
| A07440 | 32496108 | Rev Esp Enferm Dig | The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A07441 | 32495731 | Proc Nutr Soc | Report of a member-led meeting: how stable isotope techniques can enhance human nutrition research. | 2020 | Details |
| A07442 | 32494880 | Clin Exp Med | LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2. | 2020 | Details |
| A07443 | 32494762 | Curr Dev Nutr | Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models. | 2020 | Details |
| A07444 | 32494263 | Pak J Med Sci | Fatty liver in Pakistani cohort with rheumatoid arthritis. | 2022 | Details |
| A07447 | 32492133 | J Biochem | Arachidonate 12S-lipoxygenase of platelet-type in hepatic stellate cells of methionine and choline-deficient diet-fed mice. | 2020 | Details |
| A07448 | 32492075 | PLoS One | Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis. | 2020 | Details |
| A07449 | 32491288 | Physiol Int | Betanin effect on PPAR-α and SREBP-1c expression in NMRI mice model of steatohepatitis with fibrosis. | 2020 | Details |
| A07450 | 32490903 | Arq Gastroenterol | PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY. | 2020 | Details |
| A07451 | 32490750 | Physiology (Bethesda) | Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? | 2020 | Details |
| A07453 | 32490324 | Hepatol Commun | Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States. | 2020 | Details |
| A07454 | 32489856 | Integr Med Res | Herbal formulation MIT ameliorates high-fat diet-induced non-alcoholic fatty liver disease. | 2020 | Details |
| A07455 | 32489477 | J Cancer | The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis. | 2020 | Details |
| A07457 | 32488147 | Sci Rep | Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease. | 2020 | Details |
| A07458 | 32486399 | Int J Environ Res Public Health | Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults. | 2020 | Details |
| A07459 | 32486355 | Cancers (Basel) | Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective? | 2020 | Details |
| A07460 | 32486341 | Cancers (Basel) | Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma. | 2020 | Details |
| A07461 | 32486073 | Cancers (Basel) | Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. | 2020 | Details |
| A07462 | 32485838 | Int J Mol Sci | The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07463 | 32485811 | Int J Mol Sci | Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. | 2020 | Details |
| A07464 | 32485513 | Chemosphere | Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-LR (MC-LR) hepatotoxicity. | 2020 | Details |
| A07465 | 32485245 | Eur J Pharmacol | Glycyrrhetinic acid attenuates disturbed vitamin a metabolism in non-alcoholic fatty liver disease through AKR1B10. | 2020 | Details |
| A07466 | 32484830 | PLoS One | Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A07467 | 32484408 | SLAS Discov | A Framework for Optimizing High-Content Imaging of 3D Models for Drug Discovery. | 2020 | Details |
| A07468 | 32483549 | Pediatr Gastroenterol Hepatol Nutr | A Nomogram for Predicting Non-Alcoholic Fatty Liver Disease in Obese Children. | 2020 | Details |
| A07469 | 32483408 | EXCLI J | Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism. | 2020 | Details |
| A07470 | 32483260 | Sci Rep | Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk. | 2020 | Details |
| A07471 | 32483129 | Sci Rep | Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07472 | 32483086 | Eur J Gastroenterol Hepatol | Pancreatobiliary manifestations of nonalcoholic fatty liver disease: a retrospective case-control multicenter study. | 2021 | Details |
| A07473 | 32482167 | BMC Complement Med Ther | Genistein and exercise modulated lipid peroxidation and improved steatohepatitis in ovariectomized rats. | 2020 | Details |
| A07474 | 32481684 | J Clin Med | Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study. | 2020 | Details |
| A07475 | 32481590 | Cells | Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation. | 2020 | Details |
| A07476 | 32481552 | Nutrients | Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma. | 2020 | Details |
| A07477 | 32481431 | Medicine (Baltimore) | Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study. | 2020 | Details |
| A07478 | 32479709 | Transpl Infect Dis | Isolated pulmonary fusariosis caused by Neocosmospora pseudensiformis in a liver transplant recipient: A case report and review of the literature. | 2020 | Details |
| A07479 | 32478487 | Liver Int | Comparison of MAFLD and NAFLD diagnostic criteria in real world. | 2020 | Details |
| A07480 | 32478287 | Nat Metab | Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis. | 2020 | Details |
| A07481 | 32477116 | Front Pharmacol | Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. | 2020 | Details |
| A07482 | 32477115 | Front Pharmacol | Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD. | 2020 | Details |
| A07483 | 32477107 | Front Pharmacol | Gut-Derived Serotonin Contributes to the Progression of Non-Alcoholic Steatohepatitis via the Liver HTR2A/PPARγ2 Pathway. | 2020 | Details |
| A07484 | 32476802 | World J Gastroenterol | Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. | 2020 | Details |
| A07485 | 32476788 | World J Gastroenterol | Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. | 2020 | Details |
| A07486 | 32476787 | World J Gastroenterol | Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα. | 2020 | Details |
| A07487 | 32476782 | World J Gastroenterol | Natural products that target macrophages in treating non-alcoholic steatohepatitis. | 2020 | Details |
| A07488 | 32476514 | Scand J Gastroenterol | Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A07489 | 32476509 | Expert Rev Gastroenterol Hepatol | Epigenetics factors in nonalcoholic fatty liver disease. | 2020 | Details |
| A07490 | 32475980 | Med Sci Monit | Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A07491 | 32475757 | Pancreatology | Liver and pancreas: 'Castor and Pollux' regarding the relationship between hepatic steatosis and pancreas exocrine insufficiency. | 2020 | Details |
| A07493 | 32475638 | Biochem Biophys Res Commun | Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. | 2020 | Details |
| A07494 | 32475354 | Lipids Health Dis | Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis. | 2020 | Details |
| A07495 | 32475129 | Am J Physiol Gastrointest Liver Physiol | Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease. | 2020 | Details |
| A07496 | 32473093 | Mol Cell | Acetyl-CoA Derived from Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation. | 2020 | Details |
| A07497 | 32472598 | FASEB J | Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr-/- .Leiden mice. | 2020 | Details |
| A07498 | 32472585 | J Pathol | Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling. | 2020 | Details |
| A07499 | 32472368 | AMB Express | Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease. | 2020 | Details |
| A07500 | 32472367 | Curr Nutr Rep | Kefir in the Prevention and Treatment of Obesity and Metabolic Disorders. | 2020 | Details |
| A07502 | 32471118 | Nutrients | Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults. | 2020 | Details |
| A07503 | 32470880 | Int Immunopharmacol | Isolation and purification of immune cells from the liver. | 2020 | Details |
| A07504 | 32469428 | Diabetes Metab Res Rev | Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease. | 2020 | Details |
| A07505 | 32468006 | Mol Med Rep | Targeting protein palmitoylation decreases palmitate‑induced sphere formation of human liver cancer cells. | 2020 | Details |
| A07506 | 32467498 | Am J Ther | How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07507 | 32466319 | Int J Mol Sci | Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases. | 2020 | Details |
| A07508 | 32466275 | Nutrients | Blackcurrant (Ribes nigrum) Extract Prevents Dyslipidemia and Hepatic Steatosis in Ovariectomized Rats. | 2020 | Details |
| A07509 | 32463622 | Clin Transl Gastroenterol | Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07510 | 32463484 | Hepatology | Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07511 | 32463334 | Am J Physiol Gastrointest Liver Physiol | Lipid droplets disrupt mechanosensing in human hepatocytes. | 2020 | Details |
| A07512 | 32461992 | Biomed Res Int | Heme Oxygenase-1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis-Related Liver Fibrosis. | 2020 | Details |
| A07514 | 32461397 | Indian J Med Res | Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome. | 2020 | Details |
| A07515 | 32461046 | Clin Chim Acta | Emerging role of Insig-1 in lipid metabolism and lipid disorders. | 2020 | Details |
| A07516 | 32460891 | BMC Endocr Disord | Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT. | 2020 | Details |
| A07517 | 32460629 | Metab Syndr Relat Disord | The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population. | 2020 | Details |
| A07518 | 32460476 | J Pathol Transl Med | A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy. | 2020 | Details |
| A07519 | 32460399 | Liver Int | Genetic variants in the MTHFR are not associated with fatty liver disease. | 2020 | Details |
| A07520 | 32460375 | J Food Sci | Effects of polar compounds in fried palm oil on liver lipid metabolism in C57 mice. | 2020 | Details |
| A07521 | 32460191 | Biomed Pharmacother | Sodium acetate-mediated inhibition of histone deacetylase alleviates hepatic lipid dysregulation and its accompanied injury in streptozotocin-nicotinamide-induced diabetic rats. | 2020 | Details |
| A07522 | 32460140 | Atherosclerosis | Hepatocyte-like cells derived from induced pluripotent stem cells: A versatile tool to understand lipid disorders. | 2020 | Details |
| A07523 | 32457304 | Sci Rep | A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice. | 2020 | Details |
| A07524 | 32455496 | Hepatol Res | Metabolomic/lipidomic-based analysis of plasma to diagnose hepatocellular ballooning in patients with non-alcoholic fatty liver disease: A multicenter study. | 2020 | Details |
| A07525 | 32455208 | ACS Omega | Ginsenoside Rg1 Regulates Liver Lipid Factor Metabolism in NAFLD Model Rats. | 2020 | Details |
| A07526 | 32455155 | Regen Ther | Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles. | 2020 | Details |
| A07527 | 32454814 | Gastroenterol Res Pract | A Low Creatinine to Body Weight Ratio Predicts the Incident Nonalcoholic Fatty Liver Disease in Nonelderly Chinese without Obesity and Dyslipidemia: A Retrospective Study. | 2020 | Details |
| A07529 | 32454225 | Pharmacol Res | Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe. | 2020 | Details |
| A07531 | 32454173 | J Ethnopharmacol | An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity. | 2020 | Details |
| A07532 | 32454036 | Gastroenterology | ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. | 2020 | Details |
| A07533 | 32453046 | Am J Gastroenterol | Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States. | 2020 | Details |
| A07534 | 32453041 | Am J Gastroenterol | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07535 | 32451920 | Obes Surg | Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients. | 2020 | Details |
| A07536 | 32451628 | J Gastroenterol | Confounding factors of non-invasive tests for nonalcoholic fatty liver disease. | 2020 | Details |